Two Cases of Precocious Puberty Associated with Hypothalamic Hamartoma

• Published in: Clinical Pediatric Endocrinology Vol. 19; no. 2; pp. 31 - 37
• Main Authors: Shigeru Nagaki, Eiko Otsuka, Kumiko Miwa, Makoto Funatsuka, Osami Kubo, Tomokatsu Hori, Noriyuki Shibata, Tatsuo Sawada, Makiko Osawa
• Format: Journal Article
• Language: Japanese
• Published: The Japanese Society for Pediatric Endocrinology 2010
• ISSN: 0918-5739; 1347-7358

Hypothalamic hamartoma (HH) is a congenital malformation diagnosed based on magnetic resonance imaging (MRI) and histological findings; it is often associated with central precocious puberty (CPP), gelastic seizures, abnormal behavior and mental retardation. In the present paper, we report our retrospective hypothesis that there is a relationship between symptoms and therapy, as well as the treatment for HH, and describe two cases of HH associated with CPP. Both cases had sessile masses located in the interpeduncular cistern, with extension to the hypothalamus on MRI (1.2×1.5cm and 2.0×2.5cm, respectively). The first case had intractable seizures, while the second had no seizures with paroxysmal discharge. In both patients, the hamartomas were partially removed, by γ-knife and surgical operation in the first case and surgically in the second, and a gonadotropin releasing hormone (GnRH) analogue was prescribed. One case showed improvement of both intelligence quotient (IQ) score and seizures, and the other showed improvements in IQ and abnormal behavior. It was difficult to determine any topology/symptom relationships. Surgery and GnRH analogue treatment can alleviate seizures, abnormal behavior and mental retardation associated with HH.